Ulta Beauty

ULTA

----

2026-W372026-09-07

ULTA.US Weekly Report · 2026-W37

Ulta Beauty retreated 3.1% this week, sliding from 564.12 to 546.78. Despite intra-week amplitude exceeding 6%, turnover remained subdued at 0.99%. Quarterly earnings extended double-digit growth, while institutional ratings lean bullish and retail capital flowed in. However, a disconnect has emerged between improving fundamentals and price weakness.

Market Action

This week closed at 546.78, down 3.1% from the prior week’s baseline of 564.12. The intra-week high reached 547.08 and low 531.56, creating a swing range of 6.04%. Monday opened at 563, peaked at 564.84 intraday, then faced steady selling pressure over the next three sessions. Wednesday touched the week’s low near 530.8 before recovering Thursday to 546.78.

Weekly volume totaled 419,988 shares with turnover value of 228 million USD, translating to a 0.99% turnover rate. Compared to 60-day medians, volume sits at moderate levels with no significant outflows or inflows anomaly. Turnover rate aligns with normal trading—below 1% suggests neither panic nor institutional accumulation.

The pattern reflects a high open followed by progressive weakness: while intraday recovery on the final session recovered some losses, the close still failed to break above Monday’s high, signaling fading upside momentum.

Valuation & Earnings

Current P/E stands at 19.32x, placing it in the 28.3rd percentile over the past five years—meaning roughly 28% of the period saw lower valuations. Against the industry median of 9.53x, Ulta trades at a significant premium, reflecting market expectations for higher growth.

Latest quarter (Q2 FY2027, period ended September) posted EPS of $6.55, up 13.32% year-over-year; Q1 FY2027 delivered $7.74, up 15.52% YoY. Revenue for Q2 reached $3.036 billion, up 8.87% YoY—notably slower than Q1’s 11.08% growth. Net profit of $282 million grew 8.1% YoY.

Consensus forecasts peg FY2027 EPS at $30.47 (median $30.43). At current price of 546.78, this implies a forward P/E near 17.9x. While recent quarters maintained growth, the deceleration in revenue growth combined with profit growth trailing revenue growth signals cost headwinds.

Capital Flows & Institutional View

Capital flows turned positive: mid-size institutions added 743.12 units while divesting 403.51, netting +339.61. Retail investors added 1,505.10 units while selling 1,193.09, netting +312.01. Combined, smaller and medium-tier capital recorded net inflows of 651.62 units this week. Multi-layer buying interest at current levels suggests price acceptance across investor tiers.

Institutional ratings remain constructive: 15 buy, 8 hold, 4 reduce, 1 sell among 28 analysts—75% positive. Consensus target price 627.64 implies 14.8% upside from current levels. Yet ratings typically lag market pricing; institutions revise slower than capital reacts.

A notable divergence: both capital flows and consensus ratings point bullish, yet price fell 3%. This misalignment hints the market may be pricing different near-term fundamentals than consensus captures.

Summary

Ulta Beauty faced near-term pressure this week. Earnings grew double-digits, yet revenue deceleration paired with profit growth trailing revenue growth reflects operational efficiency challenges. Market capital and institutional ratings remain constructive, and the 3% pullback lacks panic selling intensity. Key watch: whether next earnings confirm growth stabilization and whether cost pressure continues to compress margins.